All‐cause mortality—same beta lactam Survival · patients with sepsis
Monotherapy showed no clear difference in all‐cause mortality—same beta lactam Survival compared with combination therapy compared (low certainty).
1 finding from 1 review
All‐cause mortality—different beta lactam · patients with sepsis
Monotherapy showed no clear difference in all‐cause mortality—different beta lactam compared with combination therapy compared (low certainty).
1 finding from 1 review
Clinical failure—same beta lactam Antibiotic modifications · patients with sepsis
It is very uncertain whether monotherapy changes clinical failure—same beta lactam Antibiotic modifications compared with combination therapy compared (very low certainty).
1 finding from 1 review
Clinical failure—different beta lactam Antibiotic modifications · patients with sepsis
It is very uncertain whether monotherapy changes clinical failure—different beta lactam Antibiotic modifications compared with combination therapy compared (very low certainty).
1 finding from 1 review
Intervention not reported
At least 50% reduction in pain or equivalent · Adults with cancer pain
1 finding from 1 review
Intervention not reported
"Moderate" benefit At least 30% reduction in pain · Adults with cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Proportion below 30/100 mm on VAS · Adults with cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Patient Global Impression of Change much or very much improved · Adults with cancer pain
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse event withdrawals · Adults with cancer pain
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Serious adverse events · Adults with cancer pain
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Death · Adults with cancer pain
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Intervention not reported
Patient‐reported disease‐specific symptom scores Symptom score with scale of 0 to 3 (0 = no symptoms, 3 = severe symptoms)
The intervention showed no clear difference in patient‐reported disease‐specific symptom scores Symptom score with… (low certainty).
1 finding from 1 review
Intervention not reported
Health‐related quality of life scores, measured by SF‐36 (range 0 to 100)
The intervention showed no clear difference in health‐related quality of life scores, measured by SF‐36 (range 0 to… (low certainty).
1 finding from 1 review
Intervention not reported
Endoscopic appearances 0 to 3 (0 = no polyps, 3 = severe polyposis)
The intervention showed no clear difference in endoscopic appearances 0 to 3 (0 = no polyps, 3 = severe polyposis) (low certainty).
1 finding from 1 review
Intervention not reported
Complications
1 finding from 1 review
Intervention not reported
Objective physiological measures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Olfactory tests
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality or liver‐related morbidity · patients with chronic hepatitis C
It is very uncertain whether the intervention changes all‐cause mortality or liver‐related morbidity (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events · patients with chronic hepatitis C
The intervention showed no clear difference in adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Failure of end of treatment virological response Absence of clearance of HCV RNA from the blood at end of treatment · patients with chronic hepatitis C
The intervention showed no clear difference in failure of end of treatment virological response Absence of… (moderate certainty).
1 finding from 1 review